But admits he does not know for sure until more data comes in.
The Indian variant (B.1.617) contains key mutations ... thus the "double mutant"
- variant has since been identified in other countries
- The BioNTech CEO said past testing of the vaccine included double mutants and he expects the shot to be effective against B.1.617.
However, Sahin said the company won't know for sure until it has more data.
Referrring to the BioNTech / Pfizer vaccine.
